HER2 Support Group Forums - What will they think of next??

PSYCHIATRIC RESEARCH STUDY
FOR CANCER PATIENTS

The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center is conducting a study designed to measure the effectiveness of the novel psychoactive medication psilocybin on the reduction of anxiety, depression, and physical pain.

In order to participate, you must:

Have stage IV cancer and anxiety.
Be between the ages of 18 - 70.
Not have cancer that affects the central nervous system or brain function.
Have no history of major psychiatric disorder.
Have no kidney disease, abnormal liver functions, diabetes, epilepsy, or cardiovascular disease, including untreated hypertension.
Not be taking insulin, oral hypoglycemic, anti-seizure, or heart medications.

If you qualify and choose to participate, you will

Spend two nights at the hospital for medication administration.
Receive psilocybin, a novel psychoactive medication.
Get an MRI scan of the brain if you have not had one recently.

For further information call:
Charles S. Grob, MD or the study nurse
at 310-222-3175

http://www.matrixmasters.com/cancera...ogo%208-04.jpg

1124 W. Carson Street
Torrance, CA 90502-2052
www.rei.edu